SEC Form 4 · accession 0001127602-17-009205
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 3:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2017 | S | 400 | $87.17 | D | 396,491 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.18 | D | 396,391 | D | |
| Common Stock | Feb 28, 2017 | S | 160 | $87.21 | D | 396,231 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.215 | D | 395,931 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.22 | D | 395,831 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.225 | D | 395,731 | D | |
| Common Stock | Feb 28, 2017 | S | 320 | $87.23 | D | 395,411 | D | |
| Common Stock | Feb 28, 2017 | S | 500 | $87.25 | D | 394,911 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.26 | D | 394,811 | D | |
| Common Stock | Feb 28, 2017 | S | 60 | $87.29 | D | 394,751 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.31 | D | 394,651 | D | |
| Common Stock | Feb 28, 2017 | S | 30 | $87.315 | D | 394,621 | D | |
| Common Stock | Feb 28, 2017 | S | 70 | $87.32 | D | 394,551 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.335 | D | 394,451 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.34 | D | 394,351 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.35 | D | 394,151 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.36 | D | 393,951 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.365 | D | 393,751 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.37 | D | 393,451 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.38 | D | 393,151 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.385 | D | 393,051 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.40 | D | 392,951 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.405 | D | 392,851 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.41 | D | 392,751 | D | |
| Common Stock | Feb 28, 2017 | S | 598 | $87.42 | D | 392,153 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.43 | D | 391,853 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.